Veriheal

SEPTEMBER 14, 2021

The findings of a new study into cannabis use disorder (CUD) among veterans have been released by a team of researchers from Pennsylvania’s Center of Excellence in Substance Addiction Treatment and Education at the Corporal Michael J. Crescenz VA Medical Center. Their hypothesis was published in the American Journal of Psychiatry.

Consumption 98

Consumption Research and Development Treatment Programs 98

Project CBD

MAY 3, 2023

a Research Associate at Chiba University in Japan, coauthored a study with Italian scientist Vincenzo Di Marzo on cannabichromene (CBC), a phytocannabinoid that exerts profound effects on the nervous system. CBC was shown to have a positive effect on neural stem progenitor cells during their maturation phase, according to in vitro research.

Cannabinoids 353

Cannabinoids Research and Development THC Terpenes 353

Puff Puff Post

SEPTEMBER 16, 2019

Santé Cannabis, a pioneer in medical cannabis in Québéc , has partnered with Spectrum Therapeutics, the medical division of Canopy Growth (TSX: WEED) (NYSE: CGC) to launch the Prescriber Training Program, designed to aid physicians and patients, announced today at the new Santé Cannabis clinic and research centre in Montréal.

Programs 108

Programs Research and Development Education Treatment 108

MGC Pharma

FEBRUARY 20, 2018

The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.

Research and Development 100

Research and Development Clinical Trials Patients Chronic Pain 100

Americans for Safe Access

MAY 25, 2021

Our lead story addresses the ISO 17065 Accreditation of our PFC program and explains why PFC becoming the first cannabis certification body to have achieved this matters so much. You will also find out how to access the recorded panels from Unity 2021 to catch anything you missed.

Research and Development 155

Research and Development DEA Banking Access 155

Cannabis Law Report

JULY 28, 2021

The study was conducted by a respected contract research organization with deep expertise in preclinical oncology model development and drug testing and data corresponding to all studied cancer cell lines have now been reported to the Company. . – July 28, 2021) – PharmaDrug Inc.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Project CBD

NOVEMBER 11, 2023

NM: As someone who has been researching cannabis for decades, how do you feel about the current legalization situation worldwide and in Japan, in particular? Dr. Andrew Weil: I think the trend very clearly is that in most developed countries, cannabis is being made legal first for medical uses and then also for recreational uses.

Medicine 306

Medicine Research and Development Pharmaceutical Cannabis 306

Veriheal

MARCH 2, 2022

Endorphins have long been connected to the runner’s high phenomenon, but new research has found that cannabinoid receptors—the very ones cannabinoids from cannabis bind to—play a key role. . The research—which summarizes nearly two decades worth of work on the matter—was conducted by Hilary Marusak and a team of other researchers.

Cannabinoids 98

Cannabinoids Research and Development Conditions Programs 98

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. The cannabis research problem. Despite the massive amount of research publications that come out year over year, many of these studies face one or more research design limitations.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

MARCH 20, 2021

CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (“Algernon”), a clinical stage pharmaceutical development company, is pleased to announce… Read More. Algernon Pharmaceuticals Inc.

Pharmaceutical 98

Pharmaceutical Programs Cannabis 98

Veriheal

APRIL 11, 2022

federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website.

Pharmaceutical 105

Pharmaceutical Research and Development DEA Clinical Trials 105

Americans for Safe Access

MAY 21, 2019

Currently, their website acknowledges that states are developing their own programs and that there is medical value to, at a minimum, isolated components of the cannabis plant, marking a shift from previous years when the agency outright ignored the progress being made at the state level.

Research and Development 189

Research and Development Policy Food Programs 189

Cannabis Law Report

JUNE 3, 2021

The agreement builds on an existing partnership between the FRB, CRAG, and IRTA formed in 2019 to develop research tools for the genetic improvement of cannabis plants. The extended partnership provides FRB the opportunity to establish their expertise as a global leader in cannabis genetics and breeding.

Agriculture 98

Agriculture Research and Development Supply Chain Hemp 98

Cannabis Law Report

JULY 13, 2021

Australia’s Victorian government says Agriculture Victoria Research scientists have developed the world’s most complete medicinal cannabis genomic reference. The organisation has been licensed by the Australian Government to undertake medicinal cannabis research. Hemp Gazette reports. Source: [link].

Medicine 81

Medicine Research and Development Agriculture Compliance 81

NORML

FEBRUARY 15, 2020

Legislation is pending, Senate Bill 165, to establish a medical marijuana access program for qualified patients with a physician’s recommendation to access medical marijuana from licensed retail outlets. Send a message to your representatives in support of ending the federal prohibition on marijuana. VA resident? WV resident?

Legislation 287

Legislation Decriminalization Access Patients 287

Cannabis Law Report

DECEMBER 27, 2019

Clinical trials are medical research projects involving human participants. However, the costs of conducting a full-scale clinical trial can be prohibitive, posing barriers to research for cannabis companies. Mobile communities advance consumer research. It offers a simple model, paying users for participation in a survey.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

Medicinal Genomics

MARCH 12, 2025

Further research is needed to determine why certain hmep varieties appear resistant, but Dr. Nachappa offered some possible reasons: Genetic diversity Hemp plants have greater genetic variation compared to clonally propagated cannabis plants. Nachappas work is the apparent resistance of hemp plants to HLVd.

Hemp 59

Hemp Research and Development Cultivation Environment 59

Cannabis Law Report

JULY 24, 2021

Argel Aguilar-Valles at Carleton University (“Carleton”) Department of Neuroscience by the Accelerate program at Mitacs for research into the anxiolytic potential of TD-010 in preclinical models of chronic anxiety and depression. About BetterLife Pharma. BetterLife Pharma Inc. About Carleton University, Department of Neuroscience.

Research and Development 98

Research and Development Treatment Therapy Media 98

Project CBD

JULY 28, 2023

From 1994 to 2013, he was employed as a principal investigator at DuPont Central Research and Development. Producing and selling psychoactive products outside the regulatory auspices of the FDA or a state-regulated cannabis program is not ethical. with unknown pharmacological and safety profiles.”

THC 217

THC Cannabinoids Hemp Research and Development 217

Cannabis Law Report

JUNE 1, 2021

Under the agreement, Native Roots will establish a new tissue culture program at their flagship Denver facility leveraging FRB’s proprietary Clean Stock® platform. At launch, the program will be the first-of-its-kind in Colorado , a differentiating factor in an increasingly competitive market.

Programs 98

Programs Supply Chain Research and Development Hemp 98

Cannabis Law Report

JULY 27, 2021

The initiative is part of Project Change Lives; Clever Leaves’ $25M product pledge to aid cannabis research in the U.S. The collaboration represents the Company’s first funded study with a research institution in the United States. organization to help advance scientific research into the potential medical benefits of cannabinoids.

Pharmaceutical 76

Pharmaceutical Research and Development Sativa Extraction 76

Cannabis Law Report

MAY 13, 2023

Matt Cartwright has announced that the National Science Foundation has awarded a $1 million Regional Innovation Engines Development award to Hazleton-based Vytal Plant Science Research for the development of an Industrial Hemp Engine as part of its newly launched Regional Innovation Engines (NSF Engines) program.

Research and Development 52

Research and Development Hemp Programs 52

Americans for Safe Access

OCTOBER 26, 2021

Check out the October 2021 issue of the ASA Activist Newsletter for updates on developments that matter for medical cannabis advocates, including Congressional action on the revived MORE Act that could end federal prohibition. In the activist profile, you'll learn about Michelle J.

Research and Development 130

Research and Development Education Events Policy 130

Veriheal

FEBRUARY 7, 2022

Now, a study from researchers at the University of Michigan has concluded that it may also be a favorite among creative geniuses of today—specifically, the software developers that make all the magic happen behind the scenes. Cannabis and Programming. Just 4% reported partaking and programming daily.

Research and Development 98

Research and Development Programs Chronic Pain Hash 98

Cannabis Law Report

JUNE 3, 2021

(OTCQB:KOAN), a Wellness Lifestyle cannabis holding company (“Resonate” or “the Company”), announced today it has retained the services of Colleen Quinn, an internationally celebrated clinical aromatherapist, cosmetic chemist, researcher and educator.

Research and Development 67

Research and Development Education Therapy Programs 67

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

AUGUST 4, 2021

A University of Adelaide project involving hemp has received a substantial grant from the Australian Research Council. 67 new research projects totalling $31.7 million were announced last week, which will see additional cash and in-kind investment of an $52 million.

Hemp 105

Hemp Research and Development Agriculture Oil 105

Cannabis Law Report

JUNE 17, 2021

goodblend™ Texas , a retail brand of Parallel , one of the nation’s largest privately-held multi-state cannabis operators, today announced the launch of the first cannabinol (CBN) products for patients registered in the Texas Compassionate Use Program.

Patients 97

Patients Programs Sleep Retail 97

Cannabis Law Report

SEPTEMBER 4, 2021

Filament has been issued the first patent for the extraction and standardization of natural psilocybin and intends to further develop its IP portfolio. The patent includes claims to the processing, extraction, and standardization of psychoactive compounds to support the company’s clinical research programs. “We

Research and Development 103

Research and Development Extraction Pharmaceutical Programs 103

CannaMD

FEBRUARY 28, 2022

A recent study carried out by researchers at the University of Michigan shows that more than 30% of programmers use cannabis while working. The primary motivations are to make programming-related tasks more enjoyable and to enhance creativity.

Research and Development 97

Research and Development Policy Programs Cannabis 97

The Cannigma

AUGUST 5, 2022

But today, thanks to a combination of changing laws and attitudes and a building consensus of scientific research, there’s another, perhaps unexpected option – ketamine. Most existing research does not support the use of THC in combating depression and there is very limited data for other cannabinoids.” ” 8 9.

Treatment 138

Treatment Research and Development Therapy Digestion 138

The Cannigma

MARCH 2, 2021

This issue is compounded when veterans do, on rare occasions, ask their doctors about medical marijuana, only to be treated as if they are mentally unstable or receive no specific health information at all,” the researchers found. This directly conflicts with past research claiming marijuana increases PTSD symptom severity.”.

Research and Development 143

Research and Development Treatment Chronic Pain Sleep 143

Cannabis Law Report

JULY 19, 2021

We don’t want to see research fall to the wayside as it has for cannabis, both in Canada and globally. LMC Manna Research is also part of hyperCORE International, which has access to more than 100 award winning research sites across two continents making them the second largest clinical research site organization globally.

Clinical Trials 75

Clinical Trials Research and Development Hybrid Medicine 75

Cannabis Law Report

JULY 8, 2021

The study is the first of its kind and will be conducted within Swinburne’s Drugs and Driving Research unit, which is led by Professor Downey. ‘We We are grateful for this grant, and especially for the opportunity to further our research in this space,’ says Professor Downey. ‘It Medicinal Cannabis Research Collaboration (MCRC).

Medicine 75

Medicine Research and Development Safety THC 75

Cannabis Law Report

AUGUST 7, 2021

MAPS PBC catalyzes healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics. We are currently focused on developing MDMA-assisted therapy as a Breakthrough Therapy for PTSD, with plans to submit for FDA approval in 2023. Key Responsibilities.

Clinical Trials 105

Clinical Trials Research and Development Compliance Compliance 105

Cannabis Law Report

SEPTEMBER 10, 2021

The announcement of a partnership between Clerkenwell Health and Octarine Bio signals a momentous time for the growth and development of the European psychedelic ecosystem. Clerkenwell Health is a psychedelic specialist clinical research organisation, based in the UK, backed with investment from VC Fund Vine Ventures, and Angel investors.

Research and Development 104

Research and Development Clinical Trials Therapy Environment 104

Veriheal

AUGUST 31, 2020

We are humbled to introduce you to them and their exceptional ideas, ranging from community grassroots mental health efforts designed to empower historically vulnerable communities of color, to research plans for identifying strain specific genetics. Program between St. Veriheal’s Innovation in Cannabis Scholarship 2020 Winners .

Research and Development 119

Research and Development Education Agriculture Patients 119